Blepharochalasis. Blepharochalasis
Conditions
Interventions
Intervention 1: After cleaning the face and injecting the local anesthetic in the upper eyelid region in the blepharopeeling group, peeling is performed in all the periocular region using phenol 89% a
Treatment - Surgery
After injecting the local anesthetic in the blepharoplasty group, the cuts are suprtficially performed with surgery blade NO.15 through the epiderm of the skin which have previously been marked are ta
After cleaning the face and injecting the local anesthetic in the upper eyelid region in the blepharopeeling group, peeling is performed in all the periocular region using phenol 89% and a cotton appl
Sponsors
Deputy of research of Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: age over 40 years; skin type : Fitzpatrick I-III; skin thickness : thin to medium; periorbitally scattered wrinkles; upper eyelid medial or lateral mild- to- medium Ptosis and informed Satisfaction to participate in the study Exclusion criteria: previous local treatment; patients dissatisfaction.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of the patient's satisfaction for eyelid prolapse. Timepoint: two months after operation. Method of measurement: questionnaire.;Rate of the patient's satisfaction for symmetry. Timepoint: two months after operation. Method of measurement: questionnaire.;Rate of the physician's satisfaction with the upper eyelid flaccidity decrease. Timepoint: two months after operation. Method of measurement: observation.;Rate of the patient's satisfaction for esthetics. Timepoint: two months after operation. Method of measurement: questionnaire.;Rate of the patient's general satisfaction. Timepoint: two months after operation. Method of measurement: questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Periorbital erythema. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Hypopigmentation. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Hyperpigmentation. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Scar. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Hematoma. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Granuloma. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Infection. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Dry eye syndrome. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Edema. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Bruising. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Loss of vision. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Diplopia. Timepoint: daily up to one week and then 2 weeks and 2 months after treatment start. Method of measurement: Visit, history and physical examination.;Lagophtalmos. Timepoint: daily up to one w | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Behzad Bafandeh
Isfahan University of Medical Science
Outcome results
None listed